Indaptus Therapeutics Q4 2025 Earnings EPS Miss Amid Continued RD Investment CHRD Q1 2026 Earnings Strong EPS Beat Driven by Operational Efficiency Figma Inc FIG Q1 2026 Earnings EPS Beats Estimates by 5576 as Profitability Strengthens OSRH Q4 2025 Earnings EPS Misses Estimates as Company Faces Operational Headwinds RCKT Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Continues Clinical Progress BDTX Q1 2026 Earnings EPS Beat but Stock Retreats 36 on Biotech Volatility